Related Experiment Videos
Agglutinin response to pertussis vaccination in the child
Insights
Infants showed a weak immune response to plain pertussis vaccines in 1967. Booster doses did not fully stimulate antibody production against all pertussis antigens, indicating potential vaccine efficacy issues.
Area of Science:
- Immunology
- Pediatrics
- Vaccinology
Background:
- Pertussis (whooping cough) is a significant childhood illness.
- Evaluating vaccine immunogenicity is crucial for public health.
- Early pertussis vaccines faced challenges in achieving consistent immune responses.
Purpose of the Study:
- To assess the agglutinin response in infants immunized with plain pertussis vaccines from different manufacturers.
- To evaluate the effectiveness of a booster dose in enhancing antibody production.
Main Methods:
- Infants received a primary course of three pertussis vaccine injections.
- A booster dose was administered five months after the primary course.
- Agglutinin antibody titers were measured to assess immune response.
Main Results:
- The primary immunization course resulted in a poor agglutinin response in most children.
- Even after a booster dose, not all vaccines elicited a response to all three pertussis agglutinogens.
- Significant variability in immunogenicity was observed among vaccines from different manufacturers.
Conclusions:
- Plain pertussis vaccines used in 1967 demonstrated suboptimal immunogenicity.
- Booster vaccination strategies may require optimization to ensure broad antigen coverage.
- Further research with contemporary vaccines and schedules is warranted to improve pertussis immunization efficacy.
Abstract:
Children were immunized with plain pertussis vaccine made by three manufacturers in 1967. After a primary course of three injections at monthly intervals, starting at 3-4 months of age, the agglutinin response was poor. Even after a "booster" dose, given five months later, not all of the vaccines had stimulated a response to all three pertussis agglutinogens. A further investigation with current vaccines of different kinds administered according to more than one schedule is recommended.